Monday, September 23, 2019
- 1:45pm-3:15pm
-
Profiling of lipoproteins and associated lipids in serum samples from Idiopathic REM Sleep Behavior Disorder patients to identify biomarkers for Parkinson’s disease
Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Progression of neuropsychiatric symptoms in Parkinson’s disease
Psychiatric Manifestations · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Progressive Myoclonus Ataxia: An International Database
Myoclonus · Les Muses, Level 3
- 1:45pm-3:15pm
-
Prolonged-release Melatonin for Sleep Disorders in Parkinson’s Disease: A Randomized trial
Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Prospective observational study to follow up a cohort of Parkinson’s outpatients during a 4-week rehabilitation
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Prospective study of cognition in SCA2
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
Prospective study on impulsive-compulsive behaviours in early Parkinson’s disease
Psychiatric Manifestations · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Psychosis in Prodromal Parkinson’s disease
Psychiatric Manifestations · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Pulmonary function in patients with Parkinson’s disease
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Quality of Life Indicators and Psycho-Social Adaptation of Patients with Essential Tremor
Quality of Life · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 75
- Next Page»